These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9659570)

  • 21. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
    Maraninchi D; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
    Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
    N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.
    Hurd DD; Peters WP
    J Natl Cancer Inst Monogr; 1995; (19):41-4. PubMed ID: 7577204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of high-dose chemotherapy for breast cancer: a review.
    Nieto Y; Champlin RE; Wingard JR; Vredenburgh JF; Elias AD; Richardson P; Glaspy J; Jones RB; Stiff PJ; Bearman SI; Cagnoni PJ; McSweeney PA; LeMaistre CF; Pecora AL; Shpall EF
    Biol Blood Marrow Transplant; 2000; 6(5):476-95. PubMed ID: 11063377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
    Ayash LJ; Wheeler C; Fairclough D; Schwartz G; Reich E; Warren D; Schnipper L; Antman K; Frei E; Elias A
    J Clin Oncol; 1995 Aug; 13(8):2043-9. PubMed ID: 7636547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM; Honegger HP; Stahel RA
    Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
    Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
    J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous bone marrow transplantation for the treatment of lung cancer.
    Lazarus HM
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):72-9. PubMed ID: 8211219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose therapy with stem cell support in solid tumors.
    Spitzer G; Dunphy FR; Bowers CE; Adkins DR
    Med Oncol; 1994; 11(2):53-62. PubMed ID: 7850264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults: principles, realization and application to the treatment of germ cell, trophoblastic, breast, ovarian and small-cell bronchial tumors. 1].
    Lotz JP; Pene F; Bouleuc C; André T; Gisselbrecht C; Bonnak H; Merad Z; Esteso A; Miccio-Bellaiche A; Avenin D
    Rev Med Interne; 1995; 16(1):43-54. PubMed ID: 7871269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy: is it standard management for any common solid tumor?
    MacNeil M; Eisenhauer EA
    Ann Oncol; 1999 Oct; 10(10):1145-61. PubMed ID: 10586330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of high-dose chemotherapy in hematology and internal medicine/ oncology].
    Engert A; Josting A; Reiser M; Söhngen D; Diehl V
    Med Klin (Munich); 1999 Aug; 94(8):431-42. PubMed ID: 10495622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy with autologous stem cell rescue in breast cancer.
    Dillman RO; Barth NM; Nayak SK; DeLeon C; O'Connor A; Morrelli L
    Breast Cancer Res Treat; 1996; 37(3):277-89. PubMed ID: 8825139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.